Tenon Medical, Inc.
TNON
$1.07
-$0.04-3.35%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 32.24% | -37.40% | 0.97% | -4.70% | -6.04% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 32.24% | -37.40% | 0.97% | -4.70% | -6.04% |
| Cost of Revenue | -14.71% | -25.99% | 61.85% | 67.47% | 14.67% |
| Gross Profit | 84.93% | -47.87% | -31.28% | -36.85% | -21.87% |
| SG&A Expenses | -0.60% | -28.48% | 0.06% | -1.73% | -6.30% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -7.70% | -28.33% | 4.21% | -0.15% | -5.09% |
| Operating Income | 18.72% | 26.21% | -4.88% | -1.02% | 4.83% |
| Income Before Tax | -4.87% | 27.63% | -1.12% | 1.50% | 4.44% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -4.87% | 27.63% | -1.12% | 1.50% | 4.44% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -4.87% | 27.63% | -1.12% | 1.50% | 4.44% |
| EBIT | 18.72% | 26.21% | -4.88% | -1.02% | 4.83% |
| EBITDA | 18.54% | 25.75% | -6.72% | -0.26% | 6.57% |
| EPS Basic | 88.85% | 95.53% | 89.96% | 90.08% | 68.95% |
| Normalized Basic EPS | 91.45% | 95.53% | 89.96% | 90.08% | 68.95% |
| EPS Diluted | 88.85% | 95.53% | 89.96% | 90.08% | 68.95% |
| Normalized Diluted EPS | 91.45% | 95.53% | 89.96% | 90.08% | 68.95% |
| Average Basic Shares Outstanding | 840.71% | 1,518.55% | 907.56% | 893.38% | 207.72% |
| Average Diluted Shares Outstanding | 840.71% | 1,518.55% | 907.56% | 893.38% | 207.72% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |